psychotomimetic


Also found in: Dictionary, Medical, Wikipedia.
Related to psychotomimetic: psychosis

psychotomimetic

[sī¦käd·ō·mi′med·ik]
(psychology)
Mimicking a psychotic disorder.
Pertaining to any drug or compound, such as lysergic acid diethylamide or mescaline, which can induce a psychotic-like state.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
As a result of the large doses for extended periods of time, irrational behavior may occur, as well as fatigue, paranoia, and psychotomimetic symptoms [24,101,117].
REL-1017 (dextromethadone) is an orally administered NMDA receptor (NMDAR) antagonist, which is active on the NMDAR ketamine binding site and has demonstrated an overall favorable safety profile without ketamine psychotomimetic adverse reactions in two Phase 1 studies.
WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801.
Svensson TH: Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs.
Most conventional nonselective NMDA receptor antagonists, however, have been implicated in adverse effects including psychotomimetic effects, impairments of learning, memory, and dissociative anesthesia.
Acute memory and psychotomimetic effects of cannabis and tobacco both 'joint' and individually: a placebo-controlled trial.Psychological Medicine .
Dysphoric reaction are less frequent and my include anxiety, fear, and psychotomimetic symptoms, but these effects are generally transient and usually do not need medical intervention (16,18,20,21).
Unlike ketamine, GLYX-13 does not elicit psychotomimetic side effects.
Seibyl et al., "Subanesthetic effects of the noncompetitive nmda antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses," Archives of General Psychiatry, vol.
The link between glutamate, NMDAR, and schizophrenia was firstly suggested by psychotomimetic symptoms induced by NMDAR noncompetitive antagonists, such as ketamine and phencyclidine, in healthy subjects [16].